ScoreWhy is Blue Jet Healthcare Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 5.42% and Operating profit at 4.70% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
- NET SALES(Latest six months) At Rs 527.78 cr has Grown at -24.08%
- PAT(Latest six months) At Rs 142.60 cr has Grown at -29.15%
- ROCE(HY) Lowest at 24.16%
3
With ROE of 17.3, it has a Very Expensive valuation with a 8 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -15.85%, its profits have fallen by -34.5%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -3.53% in the last 1 year, its fall in the stock was much higher with a return of -15.85%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Blue Jet Health for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Blue Jet Health
-15.85%
-0.33
47.61%
Sensex
-10.5%
-0.78
13.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.42%
EBIT Growth (5y)
4.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.85
Tax Ratio
25.57%
Dividend Payout Ratio
8.40%
Pledged Shares
0
Institutional Holding
9.75%
ROCE (avg)
39.16%
ROE (avg)
22.58%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
46
Industry P/E
118
Price to Book Value
8.01
EV to EBIT
42.92
EV to EBITDA
38.96
EV to Capital Employed
10.29
EV to Sales
11.93
PEG Ratio
NA
Dividend Yield
0.38%
ROCE (Latest)
26.31%
ROE (Latest)
17.27%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET SALES(Q)
At Rs 293.11 cr has Grown at 23.8% (vs previous 4Q average
PBT LESS OI(Q)
At Rs 90.71 cr has Grown at 37.5% (vs previous 4Q average
PAT(Q)
At Rs 78.26 cr has Grown at 26.3% (vs previous 4Q average
-11What is not working for the Company
NET SALES(Latest six months)
At Rs 527.78 cr has Grown at -24.08%
PAT(Latest six months)
At Rs 142.60 cr has Grown at -29.15%
ROCE(HY)
Lowest at 24.16%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.79 times
Loading Valuation Snapshot...
Here's what is working for Blue Jet Health
Net Sales - Quarterly
At Rs 293.11 cr has Grown at 23.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 236.83 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 90.71 cr has Grown at 37.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 65.97 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 78.26 cr has Grown at 26.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 61.96 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Blue Jet Health
Debtors Turnover Ratio- Half Yearly
Lowest at 2.79 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
